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Background. Reported rates of bipolar syndromes are highly variable between studies because of age differences,
differences in diagnostic criteria, or restriction of sampling to clinical contacts.
Method. In 1395 adolescents aged 14–17 years, DSM-IV (hypo)manic episodes (manic and hypomanic episodes
combined), use of mental health care, and five ordinal subcategories representing the underlying continuous score of
(hypo)manic symptoms (‘mania symptom scale ’) were measured at baseline and approximately 1.5, 4 and 10 years
later using the Munich-Composite International Diagnostic Interview (DIA-X/M-CIDI).
Results. Incidence rates (IRs) of both (hypo)manic episodes and (hypo)manic symptoms (at least one DSM-IV core
symptom) were far higher (714/105 person-years and 1720/105 person-years respectively) than traditional estimates.
In addition, the risk of developing (hypo)manic episodes was very low after the age of 21 years [hazard ratio (HR)
0.031, 95% confidence interval (CI) 0.0050–0.19], independent of childhood disorders such as attention deficit
hyperactivity disorder (ADHD). Most individuals with hypomanic and manic episodes were never in care (87% and
62% respectively) and not presenting co-morbid depressive episodes (69% and 60% respectively). The probability of
mental health care increased linearly with the number of symptoms on the mania symptom scale. The incidence of
the bipolar categories, in particular at the level of clinical morbidity, was strongly associated with previous childhood
disorders and male sex.
Conclusions. This study showed, for the first time, that experiencing (hypo)manic symptoms is a common
adolescent phenomenon that infrequently predicts mental health care use. The findings suggest that the onset of
bipolar disorder can be elucidated by studying the pathway from non-pathological behavioural expression to
dysfunction and need for care.
Received 21 September 2008 ; Revised 8 April 2009 ; Accepted 4 May 2009 ; First published online 11 June 2009
Key words : Adolescents, bipolar disorder, cohort studies, early diagnosis, epidemiology.
Introduction
The World Health Organization (WHO) identified bi-
polar disorder as the sixth leading cause of disability-
adjusted life years in the world among people aged
15–44 years (Murray & Lopez, 1996). The true preva-
lence and incidence rates (IRs) of (hypo)manic dis-
order remain unclear. Lifetime prevalence estimates
vary from around 1–2% (Regier et al. 1988 ; Kessler
et al. 1994 ; Weissman et al. 1996) to 5–8% (Carlson &
Kashani, 1988 ; Lewinsohn et al. 1995; Angst, 1998 ;
Szádóczky et al. 1998 ; Judd & Akiskal, 2003) whereas
IRs vary between 4 and 33/105 per year (Bebbington &
Ramana, 1995).
The reported variability in bipolar population mor-
bidity rates may be caused by several factors. First,
nearly all incidence studies on bipolar disorder are
based on participants in clinical care, which probably
results in a substantial underestimation of rates
(Spicer et al. 1973 ; Leff et al. 1976 ; Rasanen et al. 1998 ;
Lloyd et al. 2005 ; Kennedy et al. 2005b) because many
cases either have not sought help or are not diagnosed
correctly (Ghaemi et al. 2002).
Second, previous work suggests that the age of
the study population may be crucial, as there are
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indications that much of the population lifetime risk
for bipolar disorder is consumed in adolescence. Thus,
Lewinsohn et al. (2003) showed that, in a population
sample stratified by the age categories <9, 19–23 and
24–29 years, the first lifetime onset of bipolar disorder
and subthreshold bipolar disorder almost always oc-
curred in adolescence. Therefore, a young study popu-
lation as used in the Early Developmental Stages of
Psychopathology (EDSP) Study is most appropriate
(Wittchen et al. 2003). The issue of age is also important
in view of the considerable psychopathological,
longitudinal and familial/genetic overlap between bi-
polar disorder and childhood disorders, in particular
attention deficit hyperactivity disorder (ADHD), but
also oppositional–defiant disorder (ODD) and conduct
disorder (CD) (Nierenberg et al. 2005 ; Henin et al.
2007). Studying the onset of (hypo)manic symptoms in
adolescents allows for quantification of the amount of
the bipolar population morbidity rate that can be
traced to childhood disorders.
Third, diagnostic criteria used have a major impact
on population rates (Akiskal et al. 2000 ; Angst et al.
2003). Many people in the general population display
subthreshold bipolar disorder (Merikangas et al. 2007).
Therefore, widening criteria for bipolar disorder will
naturally increase the number of cases.
An informative way of describing the bipolar
population morbidity rate is to replace dichotomous
criteria with dimensional measures ; the possible use
of dimensional measures in bipolar disorder is cur-
rently being examined in DSM-V (First, 2006). Angst &
Marneros (2001) suggest that a natural continuum
may exist on which all (hypo)manic manifestations of
varied length, frequency and severity can be rep-
resented. This dimensional approach may be more
sensitive and informative in the search for determi-
nants of onset and change, making it easier to monitor
onset and progression of psychiatric phenotypes
(Cougnard et al. 2007 ; van Os et al. 2009). Furthermore,
it allows for fuller examination of the impact of
symptoms on well-being and functioning, severity
and distress (Regeer et al. 2006), and may facilitate
recognition of at-risk states and early intervention
(Egeland et al. 2000 ; Hanssen et al. 2005 ; Birmaher &
Axelson, 2006). For bipolar disorder, it has the ad-
ditional advantage of allowing for the separate study
of manic and depressive dimensions, the co-occur-
rence of which in the same mood episode is common
in clinical practice and therefore represents an im-
portant parameter for study in epidemiological and
taxonomic investigations. Finally, it can increase stat-
istical power without loss of clinical utility.
Therefore, the aim of the current study was to in-
vestigate dimensional (hypo)manic categories, inde-
pendent of receipt of mental health care, in a large
representative cohort of adolescents followed over a
period of up to 10 years.
Method
Sample
This examination is part of the EDSP study, a pro-
spective longitudinal cohort study. Detailed infor-
mation about the design, sample, instruments,
procedures and statistical methods of the EDSP study
is presented elsewhere (Wittchen et al. 1998b ; Lieb
et al. 2000). Data were collected in a representative
population sample of adolescents and young adults
living in the Munich area (Germany), aged 14–24 years
at baseline. The study sample was drawn randomly
from the 1994 government population registers. Four-
teen to 15-year-olds were sampled at twice the rate of
16- to 21-year-olds, and 22- to 24-year-olds were sam-
pled at half this rate.
Study design
The present study is based on a subset of EDSP re-
spondents, aged 14–17 years at baseline (T0, n=1395,
response rate 75%), thus ensuring a population at risk
of developing incident bipolar disorder. Participants
completed a baseline survey (T0, n=1395) and three
follow-up investigations (T1, T2, T3), covering a time
period of approximately 1.6 (T0–T1, S.D.=0.2), 3.4
(T0–T2, S.D.=0.3) and 8.3 years (T0–T3, range 7.4–10.6
years, S.D.=0.7) respectively. Response rates (con-
ditional on T0 completion) were 88% at T1 (n=1228),
83% at T2 (n=1169) and 73% at T3 (n=1022).
Instruments
Interviews were conducted using the computerized
version of the Munich-Composite International Diag-
nostic Interview (DIA-X/M-CIDI ; Wittchen & Pfister,
1997), an updated version of the WHO’s CIDI version
1.2 (WHO, 1990). The DIA-X/M-CIDI is a compre-
hensive, fully standardized diagnostic interview and
assesses symptoms, syndromes and diagnoses of
various mental disorders in accordance with defi-
nitions and criteria of the DSM-IV. Its features have
been developed and tested in several methodological
studies with the CIDI or modifications thereof, in-
cluding the deletion of many of the CIDI’s skipping
rules to allow for the study of subthreshold con-
ditions. High inter-rater and test–retest reliability of
the CIDI have been established (Wittchen et al. 1991 ;
Wittchen, 1994), in addition to validity (Reed et al.
1998). Test–retest reliability (k) of the DIA-X/M-CIDI
was reported to be 0.68 (p<0.001) for major depress-
ive disorder and 0.64 (p<0.001) for bipolar disorder
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(Wittchen et al. 1998a). To ensure reliability of the as-
sessments, fully trained and experienced psychol-
ogists who were allowed to probe with follow-up
questions conducted the interviews. At baseline, the
lifetime version of the DIA-X/M-CIDI was used, and
the interval version for subsequent investigations. By
using the lifetime version of the DIA-X/M-CIDI at
baseline, which includes questions regarding the time
period from birth until the interview, it was possible to
take into account the possible onset of bipolar disorder
before the baseline interview.
Mania categories based on DSM-IV algorithms
Using M-CIDI/DSM-IV diagnostic algorithms (Pfister
& Wittchen, 1995), participants were divided into four
groups, those experiencing : (1) neither hypomanic nor
manic episodes ; (2) DSM-IV manic episodes ; (3) DSM-
IV hypomanic episodes ; and (4) either manic or hy-
pomanic episodes [hereafter : (hypo)manic episodes].
The last three groups were subsequently subdivided
into participants (a) with lifetime co-morbid depress-
ive episodes and (b) without lifetime co-morbid de-
pressive episodes.
Mania categories based on symptom score
(Hypo)manic symptoms were assessed using 11 items
of the DIA-X/M-CIDI mania section, and concerned
items regarding an increase in goal-directed activity,
psychomotor agitation, spending sprees, sexual indis-
cretions, increased talkativeness, flight of ideas, in-
creased self-esteem or grandiosity, decreased need for
sleep, and distractibility. These items were rated yes
(1) or no (0) and were only rated if : (a) at least one
of the core symptoms ‘unusual happiness or excite-
ment ’ or ‘unusual irritability ’ was present ; (b) core
symptoms were either noticed by others or caused
participants problems; (c) symptoms were present for
at least four successive days; (d) symptoms were not a
result of alcohol/drugs use. Guided by previous work
(Regeer et al. 2006), a sum score of symptom ratings
was formed (range 0–11 symptoms). Five progress-
ively stricter and overlapping subcategories of this
sum score were created (I, no symptoms; II, o1
symptom; III, o4 symptoms; IV, o7 symptoms; V,
o10 symptoms), which represented the underlying
continuous score of (hypo)manic symptoms.
Mania categories based on distress
In participants with o4 (hypo)manic symptoms, a
division was made based on the level of distress, as
reported in the DIA-X/M-CIDI mania section. Distress
was assessed by asking participants if, at the moment
the symptoms were at their worst, they interfered with
life, work or leisure activities, and was coded (1) no
interference, (2) some interference, (3) considerable in-
terference and (4) much interference.
Grouping by mental health care
In participants fulfilling criteria for at least one of the
above categories, grouping was applied based on
whether or not mental health care had been received
at the respective assessment. First, participants were
asked if they had ever been treated in a hospital or had
spoken to a professional because of (hypo)manic
symptoms. Second, participants were shown a list on
which several types of out-patient, in-patient or day-
patient institutions for mental health problems were
mentioned, after which they were asked if they had
ever sought help at any of these institutions because
of mental health problems. All participants who re-
sponded positively to either one of these questions
were considered to have received mental health care.
Childhood disorders
Between T0 and T1, face-to-face interviews were car-
ried out with respondents’ parents to collect infor-
mation regarding ODD, CD and ADHD (hereafter
collectively referred to as ‘childhood disorders ’).
These childhood disorders were assessed with ques-
tions covering the criteria defined by the DSM-IV.
Information was mostly based on maternal responses
(97.4%). The response rate of parents was 86%
(n=1053).
Statistical analysis
Cumulative lifetime incidence (CLI) and person-year IRs
Weighting occurred to account for differences in sam-
pling probabilities and also systematic non-response
at baseline according to age, gender and geographical
location (Lieb et al. 2000). Cumulative lifetime inci-
dence up to T3 (CLI) of the (hypo)manic categories
was calculated at T3.
Survival analysis was conducted to determine IRs
between T0 and T3 using the ST commands in Stata,
version 9.2 (StataCorp, 2005). CLI and IR estimates
were calculated, grouping by receipt of mental health
care. The IR is defined as the number of new cases of
disease during a given time period divided by the sum
of time that each person remains under observation
and is free from disease (the total person-time of ob-
servation). After defining appropriate risk sets, IRs
were calculated for each category. The risk set is de-
fined as the set of individuals at risk of belonging to a
certain category for the first time during the study.
Therefore, participants with past or current evidence
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of this category at baseline were excluded from
analysis, in which the strictest possible exclusion cri-
teria were used [e.g. all participants experiencing o1
symptom were excluded for analyses of incidence of
(hypo)manic symptoms]. The total person-times of ob-
servation of the individual risk sets thus defined are
presented in Table 1.
Childhood morbidity sensitivity analyses
To assess how much of the incidence of bipolar cat-
egories could be traced to childhood morbidity, co-
morbidity with childhood disorders was assessed and
childhood morbidity sensitivity analyses (CMSAs)
performed. First, lifetime co-morbidity between T0
lifetime (hypo)manic episodes and childhood dis-
orders was assessed using logistic regression. Second,
Cox regression was used to calculate associations be-
tween childhood disorders and incidence of new
(hypo)manic episodes between T0 and T3. Third, CLI
and IRs for (hypo)manic episodes were recalculated
with exclusion of individuals with these childhood
disorders. Similar sensitivity analyses were performed
for other (hypo)manic categories.
Demographic risk factors
IRs were calculated stratified by age group as a time-
varying variable (15–16, 17–18, 19–21, 22–24 and 25–28
years ; age=age during any moment of the study), sex
and urbanicity [living in city or rural area at baseline ;
city area=city of Munich (population density 4061
persons per square mile) and rural area=the Munich
surrounding area (population density 553 persons per
square mile)] (Spauwen et al. 2006). Statistical differ-
ences in IRs within age, sex or urbanicity categories
were tested using Cox regression analysis yielding
hazard ratios (HRs), using the 15-year age group, male
sex, and rural area as reference categories (Table 2).
To assess whether any association with demographic
factors was independent of the others and uncon-
founded by co-morbid current or childhood psycho-
pathology, HRs of all categories were adjusted for age,
sex, urbanicity, presence of depression (diagnosis of a
lifetime DSM-IV depressive episode) and presence of
childhood disorders (diagnosis of either ODD, CD or
ADHD according to DSM-IV criteria) using the Stata
STRATA option for adjustment by stratification in Cox
regression. HRs of the distress categories were ad-
ditionally adjusted for number of (hypo)manic symp-
toms (as indexed by the continuous sum score of
symptom ratings). As part of the CMSA, HRs were
calculated similarly after exclusion of participants suf-
fering from childhood disorders.
Results
Analyses are based on 1395 adolescents (51% male).
The mean age at baseline was 15.1 years (S.D.=1.1).
Four-hundred and fifteen adolescents (30%) were liv-
ing in a rural area. Of the 1395 adolescents, 1022 com-
pleted T3. Attrition rates were almost equal for sex
(28.8% females v. 24.8% males), urbanicity (25.3% ru-
ral v. 27.3% city), and age (22.4% 13-year-olds v. 23.8%
14-year-olds v. 29.6% 15-year-olds v. 25.7% 16-year-
olds v. 29.5% 17-year-olds).
Incidence of DSM-IV (hypo)manic episodes
CLI rates varied between 1.3% and 7.6% for the dif-
ferent DSM-IV episodic groups, declining after re-
striction to episodes plus mental health care (Table 1).
Table 1. Cumulative lifetime incidence up to T3 and incidence rates (T0–T3) of (hypo)manic episodes, stratified by care
(Hypo)manic group Restriction
CLI up to T3a IR (T0–T3)b
Totalc DEP+ DEPx Totalc DEP+ DEPx
DSM-IV manic episode None 3.3 (45) 1.3 (18) 2.0 (27) 308.9 (28.7/9277) 103.8 (9.8/9403) 201.9 (18.9/9358)
MHC+ 1.2 (17) 0.6 (9) 0.6 (8) 113.9 (10.7/9419) 50.6 (4.8/9448) 62.9 (5.9/9454)
DSM-IV hypomanic
episode
None 4.5 (62) 1.4 (20) 3.1 (43) 409.5 (37.6/9184) 165.9 (15.6/9410) 237.6 (22.0/9258)
MHC+ 0.6 (8) 0.3 (4) 0.3 (4) 27.5 (2.6/9437) 24.5 (2.3/9467) 2.9 (0.3/9453)
DSM-IV (hypo)manic
episoded
None 7.6 (106) 2.7 (37) 4.9 (69) 713.5 (64.1/8982) 262.3 (24.5/9334) 433.7 (39.6/9131)
MHC+ 1.8 (25) 0.8 (12) 0.9 (13) 132.6 (12.4/9376) 65.8 (6.2/9436) 66.0 (6.2/9424)
CLI, Cumulative lifetime incidence ; IR, incidence rate ; MHC+, episodes in combination with mental health care ;
DEP+, with depressive episode ; DEP–, without depressive episode.
a Values are expressed as percentage (number) of cases.
b Values are expressed as number of cases per 100 000 person-years (denominator is population of person-years).
c Total group, independent of having lifetime depressive episodes.
d (Hypo)manic episode : either hypomanic or manic episode.
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Approximately a third of participants had co-morbid
depressive episodes. IRs ranged from 104/105 to 714/
105 person-years, declining after restriction to episodes
plus mental health care (Table 1).
Incidence of (hypo)manic symptoms
The number of participants steadily declined with in-
creasing level of symptoms (Table 3). For participants
experiencing o1 symptom, the CLI was six times
higher before restriction of the group to participants
with symptoms plus mental health care (Table 3). This
discrepancy between CLI rates decreased as the num-
ber of symptoms increased.
Incidence of distress
CLI and IRs are presented in Table 4. Higher rates of
distress were experienced by fewer people. The ma-
jority of people with ‘some distress ’ remained outside
care, and the majority of people with ‘much distress ’
were in care.
Table 2. Predictors of incident (hypo)manic categories
Risk of incident (hypo)manic category, HR (95% CI)b
Age (RC: 15-year
age group)
Female v. Male
(RC: male sex)
City v. Rural
(RC: rural)
Childhood disorder
(ODD, CD or ADHD)
Manic episode 0.74 (0.50–1.10) 0.07 (0.065–0.79)* 1.55 (0.37–6.57) 3.65 (0.92–14.45)
Hypomanic episode 0.65 (0.50–0.85)** 1.55 (0.62–3.85) 1.08 (0.42–2.77) 7.82 (1.94–31.60)*
(Hypo)manic episodea 0.67 (0.54–0.84)** 0.75 (0.36–1.56) 1.21 (0.55–2.66) 5.29 (2.01–13.91)**
o1 symptom 0.63 (0.55–0.72)** 1.40 (0.94–2.08) 1.15 (0.75–1.77) 0.83 (0.36–1.92)
o4 symptoms 0.60 (0.51–0.72)** 1.46 (0.88–2.43) 1.10 (0.64–1.89) 1.06 (0.38–2.92)
o7 symptoms 0.61 (0.45–0.85)* 0.40 (0.13–1.18) 4.51 (0.94–21.72) 2.38 (0.50–11.31)
o10 symptoms 0.34 (0.11–1.06) 0.60 (0.05–6.79) 5.44 (0.28–107.42) N.A.
Some distress 0.66 (0.49–0.89)* 0.99 (0.38–2.61) 1.10 (0.43–2.80) 0.95 (0.24–3.71)
Much distress 0.69 (0.43–1.10) N.A. 0.56 (0.07–4.46) 1.23 (0.19–8.16)
Considerable distress 0.87 (0.34–2.21) N.A. 0.93 (0.03–26.96) N.A.
Psychiatric help 0.34 (0.13–0.86)* 2.73 (0.20–36.77) N.A. N.A.
HR, Hazard ratio ; CI, confidence interval ; RC, reference category ; ODD, oppositional–defiant disorder ; CD, conduct
disorder ; ADHD, attention deficit hyperactivity disorder ; N.A., not applicable.
a (Hypo)manic episode : either hypomanic or manic episode.
b Results adjusted for age, sex, urbanicity, depression and childhood disorders. In case of distress/psychiatric help category :
results also adjusted for number of (hypo)manic symptoms.
* pf0.05, ** pf0.001.
Table 3. Cumulative lifetime incidence up to T3 and incidence rates (T0–T3) of
(hypo)manic symptoms, stratified by care
(Hypo)manic category Restriction CLI up to T3a IR (T0–T3)b
o1 symptom None 37.9 (528) 1720.0 (153.2/8909)
MHC+ 6.3 (87) 363.7 (32.9/9054)
o4 symptoms None 26.5 (370) 1112.2 (101.0/9080)
MHC+ 4.8 (67) 225.6 (21.0/9145)
o7 symptoms None 8.5 (119) 377.9 (35.4/9379)
MHC+ 2.4 (34) 94.7 (8.8/9328)
o10 symptoms None 1.0 (13) 77.9 (7.4/9455)
MHC+ 0.5 (7) 27.7 (97.3/9075)
CLI, Cumulative lifetime incidence ; IR, incidence rate ; MHC+, episodes in
combination with mental health care.
a Values are expressed as percentage (number) of cases.
b Values are expressed as number of cases per 100 000 person-years (denominator
is population of person-years).
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Association with childhood disorders
Seventy-six participants (7.2%) were diagnosed with
any childhood disorder, mostly with ADHD (4.1%).
Being diagnosed with a childhood disorder did not
increase the risk of belonging to any (hypo)manic
category at T0 (for detailed results see Tables 1-B, 1-D
and 1-E at www.mania.homestead.com). The associ-
ation between the incident (hypo)manic categories
and childhood morbidity was large and significant
[HR 5.29, 95% confidence interval (CI) 2.01–13.91,
p=0.001 for (hypo)manic episode] (Table 2). Thus,
CMSAs reduced incidence rates (at most) by a factor of
2 according to the (hypo)manic category (see Table 1-C
at www.mania.homestead.com).
Age, sex and urbanicity
A strong association existed between age and IRs for
all (hypo)manic categories (Table 2, Figs 1–3), with IRs
decreasing as age increased. Post-hoc analyses showed
Table 4. Cumulative lifetime incidence up to T3 and incidence rates (T0–T3) of distress,
stratified by carea
(Hypo)manic category Restriction CLI up to T3b IR (T0–T3)c
Some distress None 10.8 (151) 1072.7 (97.3/9075)
MHC+ 1.8 (25) 167.0 (15.6/9358)
Much distress None 4.1 (58) 267.0 (25.0/9371)
MHC+ 1.0 (14) 96.2 (9.1/9436)
Considerable distress None 0.8 (12) 51.4 (4.9/9468)
MHC+ 0.2 (3) 18.4 (1.7/9464)
CLI, Cumulative lifetime incidence ; IR, incidence rate ; MHC+, episodes in
combination with mental health care.
a In participants with o4 (hypo)manic symptoms.
b Values are expressed as percentage (number) of cases.
c Values are expressed as number of cases per 100 000 person-years (denominator
is population of person-years).
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Fig. 1. Incidence of (hypo)manic disorder, stratified by age
and care. ––&––, (Hypo)manic episodea,b ; - -&- -,
(hypo)manic episodea,b, MHC+. MHC+, episodes in
combination with mental health care. a (Hypo)manic
episode : either hypomanic or manic episode. b Independent
of having lifetime depressive episodes.
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Fig. 2. Hazard ratios of incident (hypo)manic categories,
stratified by age group. ––&––, (Hypo)manic episodea,b,d ;
  n  , o1 symptomd; - -2- -, some distressc,e. Reference
category : the 19–21 years age group. a (Hypo)manic
episode : either hypomanic or manic episode. b Independent
of having lifetime depressive episodes. c In participants with
o4 (hypo)manic symptoms. d Results adjusted for sex,
urbanicity, depression and childhood disorders
[oppositional–defiant disorder (OD), conduct disorder (CD)
or attention-deficit/hyperactivity disorder (ADHD)].
e Results adjusted for sex, urbanicity, depression, childhood
disorders (ODD, CD or ADHD) and number of (hypo)manic
symptoms.
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Fig. 3. Incidence of experienced distress in participants with
o4 (hypo)manic symptoms, stratified by age and care.
––m––, Some distress ;   m  , some distress, MHC+.
MHC+, distress in combination with mental health care.
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that the IRs of episodic categories, compared to the
age group 15–21 years, decreased very strongly after
the age of 21 years [HR 0.021, 95% CI 0.0024–0.18,
p=0.000 for hypomanic episode; HR 0.031, 95% CI
0.0050–0.19, p=0.000 for (hypo)manic episode], with
a similar decline (albeit statistically inconclusive)
after restriction to episodes plus mental health care.
Subsequent CMSAs showed a similar pattern of as-
sociations (see Table 1-C, Figs 2-B and 3-B at www.
mania.homestead.com).
The incidence of manic episodes was 14 times lower
in women compared to men (HR 0.072, 95% CI 0.065–
0.79, p=0.031). However, no sex differences were
present for other (hypo)manic categories and there
was no association with urbanicity. In the CMSA, a
male preponderance in incidence of manic episodes
remained (HR 0.08, 95% CI 0.070–0.86, p=0.037),
whereas a female preponderance was seen in the cat-
egory with o1 symptom (HR 1.51, 95% CI 1.01–2.26,
p=0.045).
Discussion
Findings
In this large prospective study of over 1000 ado-
lescents and young adults, the results show that IRs of
both (hypo)manic episodes and (hypo)manic symp-
toms are much higher than those reported previously,
and that the risk of developing a disorder is very low
after the age of 21 years, independent of childhood
disorders such as ADHD. In addition, the results
demonstrate a continuous distribution of (hypo)manic
symptoms and distress, thus supporting the hypoth-
esis that a dimensional representation may usefully
describe the (hypo)manic phenotype (Allardyce et al.
2007). Only a small fraction of adolescents and young
adults experiencing these phenomena were receiving
psychiatric care and the co-occurrence of (hypo)manic
episodes with depression was low compared to most
of the literature. The incidence of the (hypo)manic
categories, in particular categories at the level of
clinical morbidity, was strongly associated with pre-
vious childhood disorders and male sex. In con-
clusion, this study showed, for the first time, that
experiencing (hypo)manic symptoms is a common
adolescent phenomenon that infrequently predicts
mental health care use. The findings suggest that the
onset of bipolar disorder can be elucidated by study-
ing the pathway from non-pathological phenotypic
expression to disability.
Limitations
Several limitations need to be considered. First, al-
though a prospective design was used, the study
became partly retrospective by implementing ques-
tions regarding time intervals between waves. There-
fore, the possibility of recall bias cannot be excluded,
although arguably this would be likely to contribute
more to false negatives than false positives (Simon &
VonKorff, 1995).
Second, exclusion of individuals at T0 and exclusion
of the older cohort means that the results are based on
a limited age range with an associated decrease in
statistical power. This could have caused the incidence
to fall after the age of 21 years. However, similar re-
sults were found after the oldest two age groups were
collapsed, thus increasing statistical power.
Third, the age range of participants was limited as
follow-up of participants did not begin until the age of
14 years. Future studies should examine whether ado-
lescent bipolar symptoms, relevant to adult clinical
morbidity, are present also in younger samples.
Fourth, the analyses of childhood disorders were
all based on retrospective parental report. This may
have influenced the reliability of the results. However,
Faraone et al. (1995) have shown that maternal reports
of their children’s psychopathology by 1-year recall
provided a reliable and accurate means of assessment.
In addition, the rates found for the childhood dis-
orders analysed in this study are comparable to the
rates found in other studies (Costello et al. 2003),
which likewise attests to their validity.
Fifth, the predictive validity of the broad category of
(hypo)manic symptoms may be enhanced by testing
whether (hypo)manic symptoms can also predict de-
pression. Testing this in a post-hoc analysis revealed
that participants who had at least two (hypo)manic
symptoms once at T0, T1 or T2 had a nearly twofold
higher risk of ever experiencing a depressive epi-
sode compared to participants with less than two
(hypo)manic symptoms at T0/T1/T2.
Cumulative incidence and person-year incidence rates
IRs in this study are much higher than those reported
previously (Bebbington & Ramana, 1995). A partial
explanation for this discrepancy may be the use of
clinical samples in previous work. The effect of sample
type on observed IRs is clearly shown in the current
data, in which grouping for mental health care de-
creased IRs. However, the elevated IRs cannot be ex-
plained entirely by sample type because even for
participants receiving mental health care, IRs were still
higher than previously reported estimates, whereas
CLI estimates did yield estimates comparable to those
in previous reports (Lish et al. 1994). One reason for
the higher IRs may be that the current sample con-
sisted of adolescents, who display the highest risk
of developing mental disorders (Kessler et al. 2005).
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The focus on clinical samples might also explain
the low co-occurrence of depressive episodes with
(hypo)manic episodes because both types of episodes,
independently of each other, increase need for care
and help-seeking, resulting in more ‘co-morbid’ psy-
chopathology at the level of mental health care
(‘Berkson’s bias ’) (Regeer et al., in press). Accordingly,
the co-occurrence of depressive episodes in the current
study was higher in participants receiving mental
health care.
Bipolar disease as a developmental disorder
The greatest risk of developing (hypo)manic episodes
was before age 22 years, after which it decreased to the
point of almost disappearing. This finding is sup-
ported by other studies in which the most common
age of onset for bipolar disorder was reported to be
between 15 and 19 years (Szádóczky et al. 1998).
Findings similarly concur with studies in which sub-
stantial numbers of adult patients retrospectively re-
ported first experiencing symptoms in childhood
or adolescence (Joyce, 1984). The findings in the cur-
rent sample show low levels of cross-sectional co-
morbidity of childhood disorders with (hypo)manic
categories at T0, but very high longitudinal co-
morbidity with new, incident bipolar categories, in
particular at the level of clinical morbidity, over time.
The CMSA in which childhood disorders were ex-
cluded did not change the pattern of association
with age. The pattern of findings therefore suggests
that the ontogenesis of (hypo)manic symptoms and
(hypo)manic disorder may be traced to the adolescent
developmental period and that expression of certain
childhood disorders may increase the risk for later
expression of bipolar morbidity.
Continuity
The current results suggest that (hypo)manic symp-
toms may represent a common phenomenon in the
general population. Symptoms and clinical morbidity
showed dose–response relationships, in that more
cases of clinical morbidity arose as the number of
symptoms increased, supporting continuity between
subclinical and clinical categories. Evidence for conti-
nuity has been provided by others (Angst et al. 2003 ;
Lewinsohn et al. 2003 ; Regeer et al. 2006). However,
as evidenced by findings in the current study, the
vast majority of these individuals with symptomatic
expression never develop bipolar disorder. Thus,
(hypo)manic symptoms may be conceived partially
as pertaining to normal adolescent development.
If, however, symptoms persist over time, individuals
may be at risk of transition to bipolar disorder
(Cougnard et al. 2007). Thus, future work should in-
vestigate whether adolescents with persistent (hypo)-
manic symptoms are at risk of making the transition to
bipolar disorder, and which factors drive such tran-
sitions. Possible factors are symptom factors (intru-
siveness, frequency and co-morbidity of symptoms),
personal and cultural factors (coping, illness behav-
iour, societal tolerance and the development of func-
tional impairments), and known bipolar risk factors
(a positive family history, exposure to life events, or an
interaction between these factors) (Lapalme et al. 1997 ;
van Os & Verdoux, 2003 ; Hillegers et al. 2004; van Os
et al. 2009).
Risk factors
Male sex was a risk factor for the onset of manic epi-
sodes. This is inconsistent with studies finding equal
sex distributions (Lloyd et al. 2005). However, the
finding does concur with several studies in which it
was suggested that male sex is associated with earlier
onset of mania (Carlson et al. 2000 ; Kennedy et al.
2005a). Male preponderance in incidence was not
seen for subclinical bipolar categories, suggesting that
male sex specifically increases the risk for clinical
morbidity. The link between male sex and poor out-
come is well known for other types of psychotic ill-
ness, in particular schizophrenia (Castle & Murray,
1991).
Urbanicity generally did not increase the risk for
(hypo)manic categories. This concurs with previous
findings (Krabbendam& van Os, 2005). A recent study
showed any association between (hypo)manic dis-
order and urbanicity is probably mediated by positive
psychotic symptoms (Kaymaz et al. 2007).
Clinical implications
Several clinical implications are suggested by this
study. First, given the possible wide distribution of
low-grade bipolar experiences, the suggested specific
developmental phase of expression and evidence that
subclinical expression of bipolarity increases the risk
for later bipolar disorder in a dose–response fashion
(Regeer et al. 2006), a public health approach focusing
on targeted early identification may merit further in-
vestigation. Second, work focusing on psychotic dis-
order has indicated that subclinical phenotypes may
be more likely to make the transition to the fully de-
veloped disorder if there is persistence over time
(Cougnard et al. 2007 ; Dominguez et al., in press).
Thus, examining patterns and determinants of per-
sistence of subclinical expression of bipolar experi-
ences may be similarly instructive. Third, the findings
suggest that greater symptom load and greater levels
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of distress are associated with a higher probability
of the outcome of mental health care. Understanding
the dynamics between symptoms, distress and help-
seeking is necessary to develop early interventions.
Fourth, the findings suggest that only a minority of
those with bipolar experiences are in care, similar to
findings in depression and anxiety disorders. Given
that, in depression, subsyndromal expression is asso-
ciated with a substantial amount of disability (Judd
et al. 2002), individuals with subclinical bipolar ex-
periences not receiving care may similarly have a
considerable degree of disability that could be reduced
if recognized and treated.
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The prevalence of major depressive and bipolar disorders
in Hungary : results from a national epidemiologic survey.
Journal of Affective Disorders 50, 153–162.
van Os J, Linscott RJ, Myin-Germeys I, Delespaul P,
Krabbendam L (2009). A systematic review and
meta-analysis of the psychosis continuum: evidence for
a psychosis proneness-persistence-impairment model of
psychotic disorder. Psychological Medicine 39, 179–195.
van Os J, Verdoux H (2003). Diagnosis and classification of
schizophrenia : categories versus dimensions, distributions
versus disease. In The Epidemiology of Schizophrenia
(ed. R. M. Murray, P. Jones, E. Susser, J. van Os and
M. Cannon), pp. 364–410. Cambridge University Press :
Cambridge.
Weissman MM, Bland RC, Canino GJ, Faravelli C,
Greenwald S, Hwu H-G, Joyce PR, Karam EG, Lee C-K,
Lellouch J, Lepine J-P, Newman SC, Rubio-Stipec M,
Wells JE, Wickramaratne PJ, Wittchen H-U, Yeh E-K
(1996). Cross-national epidemiology of major depression
and bipolar disorder. Journal of the American Medical
Association 276, 293–299.
WHO (1990). Composite International Diagnostic Interview
(CIDI), Version 1.0. World Health Organization : Geneva,
Switzerland.
Wittchen H-U (1994). Reliability and validity studies of the
WHO-Composite International Diagnostic Interview
(CIDI) : a critical review. Journal of Psychiatric Research 28,
57–84.
Wittchen H-U, Lachner G, Wunderlich U, Pfister H (1998a).
Test–retest reliability of the computerized DSM-IV version
of the Munich-Composite International Diagnostic
Interview (M-CIDI). Social Psychiatry and Psychiatric
Epidemiology 33, 568–578.
Wittchen H-U, Mühlig S, Pezawas L (2003). Natural course
and burden of bipolar disorders. International Journal of
Neuropsychopharmacology 6, 145–154.
Wittchen H-U, Perkonigg A, Lachner G, Nelson CB (1998b).
Early Developmental Stages of Psychopathology study
(EDSP) : objectives and design. European Addiction Research
4, 18–27.
Wittchen H-U, Pfister H (1997). DIA-X-Interviews :
Manual for the screening procedure and interview;
Longitudinal Interview (DIA-X-Lifetime) ; Additional
Book (DIA-X-Lifetime) ; Cross-sectional Interview
(DIA-X-12 monthly version) ; Additional Book (DIA-X-12
monthly version) ; Computer program to execute the
interviews (longitudinal and cross-sectional studies).
Analysis program. Swets & Zeitlinger : Frankfurt,
Germany.
Wittchen H-U, Robins LN, Cottler LB, Sartorius N,
Burker JD, Regier D (1991). Cross-cultural feasibility,
reliability and sources of variance of the Composite
International Diagnostic Interview (CIDI). The Multicentre
WHO/ADAMHA Field Trials. British Journal of Psychiatry
159, 645–653, 658.
Bipolar disorder : the poor outcome of a common developmental phenotype 299
